234 filings
Page 2 of 12
D
BFRI
Biofrontera Inc
5 Mar 24
$8.00 mm in equity / options / securities to be acquired, sold $8.00 mm, 8 investors
5:20pm
8-K
BFRI
Biofrontera Inc
23 Feb 24
Biofrontera Inc. Announces Closing of Private Placement of Up To $16.0 Million priced at market per Nasdaq rules
9:26am
8-K
BFRI
Biofrontera Inc
20 Feb 24
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
9:37am
RW
BFRI
Biofrontera Inc
20 Feb 24
Registration withdrawal request
7:55am
SC 13G
Armistice Capital, LLC
14 Feb 24
Biofrontera / ARMISTICE CAPITAL ownership change
3:28pm
8-K
BFRI
Biofrontera Inc
12 Feb 24
Other Events
9:39pm
8-K
BFRI
Biofrontera Inc
5 Feb 24
Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for AmeluzĀ® to Permit Up to Three Tubes per Use
5:25pm
8-K
BFRI
Biofrontera Inc
2 Feb 24
Entry into a Material Definitive Agreement
4:30pm
S-1/A
BFRI
Biofrontera Inc
IPO registration (amended)
29 Jan 24
9:23am
8-K
BFRI
Biofrontera Inc
25 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
S-1
BFRI
Biofrontera Inc
IPO registration
16 Jan 24
7:23pm
8-K
BFRI
Biofrontera Inc
11 Jan 24
Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023
4:40pm
8-K/A
BFRI
Biofrontera Inc
9 Jan 24
Termination of a Material Definitive Agreement
5:01pm
8-K
BFRI
Biofrontera Inc
3 Jan 24
Entry into a Material Definitive Agreement
5:27pm
8-K
BFRI
Biofrontera Inc
28 Dec 23
Entry into a Material Definitive Agreement
5:25pm
8-K
BFRI
Biofrontera Inc
27 Dec 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
BFRI
Biofrontera Inc
15 Dec 23
Entry into a Material Definitive Agreement
5:00pm
8-K
BFRI
Biofrontera Inc
29 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
DEF 14A
BFRI
Biofrontera Inc
Definitive proxy
17 Nov 23
6:02am
10-Q
2023 Q3
BFRI
Biofrontera Inc
Quarterly report
9 Nov 23
5:23pm